Literature DB >> 7803763

Regulation and functions of the glycogen synthase kinase-3 subfamily.

J R Woodgett1.   

Abstract

Glycogen synthase kinase-3 is a 'black sheep' among protein kinases. Although its name suggests a primary function in intermediary metabolism, its scope is far more diverse as indicated by both genetic and biochemical evidence. Over the past five years the enzyme has emerged as an important component of transduction pathways ultimately regulating cell fate and differentiation. The molecular mechanisms underlying these functions are only just being unraveled but point to a novel mode of cellular regulation conserved in all eukaryotes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803763

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  36 in total

1.  Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.

Authors:  Gerardo Morfini; Györgyi Szebenyi; Ravindhra Elluru; Nancy Ratner; Scott T Brady
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

2.  Regulation of the nuclear export of the transcription factor NFATc1 by protein kinases after slow fibre type electrical stimulation of adult mouse skeletal muscle fibres.

Authors:  Tiansheng Shen; Zoltán Cseresnyés; Yewei Liu; William R Randall; Martin F Schneider
Journal:  J Physiol       Date:  2006-12-21       Impact factor: 5.182

3.  The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors.

Authors:  Michael Bordonaro; Darina L Lazarova; Alan C Sartorelli
Journal:  Exp Cell Res       Date:  2007-02-22       Impact factor: 3.905

Review 4.  Processive phosphorylation: mechanism and biological importance.

Authors:  Parag Patwardhan; W Todd Miller
Journal:  Cell Signal       Date:  2007-06-22       Impact factor: 4.315

5.  Regulation of ribosomal S6 protein kinase-p90(rsk), glycogen synthase kinase 3, and beta-catenin in early Xenopus development.

Authors:  M A Torres; H Eldar-Finkelman; E G Krebs; R T Moon
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  Lithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer.

Authors:  Akiva P Novetsky; Dominic M Thompson; Israel Zighelboim; Premal H Thaker; Matthew A Powell; David G Mutch; Paul J Goodfellow
Journal:  Int J Gynecol Cancer       Date:  2013-02       Impact factor: 3.437

7.  Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.

Authors:  Tatiana V Lipina; Oksana Kaidanovich-Beilin; Satish Patel; Min Wang; Steven J Clapcote; Fang Liu; James R Woodgett; John C Roder
Journal:  Synapse       Date:  2011-03       Impact factor: 2.562

8.  Interaction of yeast repressor-activator protein Ume6p with glycogen synthase kinase 3 homolog Rim11p.

Authors:  K Malathi; Y Xiao; A P Mitchell
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

9.  The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies.

Authors:  Cyril Sobolewski; Claudia Cerella; Mario Dicato; Lina Ghibelli; Marc Diederich
Journal:  Int J Cell Biol       Date:  2010-03-17

10.  NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.

Authors:  Young-Jun Kim; Sun Y Yoon; Jong-Tae Kim; Eun Y Song; Hee G Lee; Hyun J Son; Soo Y Kim; Daeho Cho; Inpyo Choi; Joo H Kim; Jae W Kim
Journal:  Carcinogenesis       Date:  2009-02-23       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.